Angus W G, Mousa M A, Vargas V M, Quensen J F, Boyd S A, Contreras M L
Department of Pharmacology and Toxicology, Michigan State University, East Lansing 48824, USA.
Neurotoxicology. 1997;18(3):857-67.
PC12 cells were used to examine the mechanisms by which polychlorinated biphenyls (PCBs) reduce cellular levels of dopamine (DA). In cells treated 3 days with Aroclor 1254, 2,2',5,5'-tetrachlorobiphenyl (2,2',5,5'-TCB), or 2,2',3,3',4,4'-hexachlorobiphenyl (2,2',3,3',4,4'-HCB), the PCB-mediated reduction in 3H-tyrosine uptake was observed only at high PCB concentrations that produced a reduction in DNA levels. The PCB congener, 2,2',4,4',5,5'-hexachlorobiphenyl (2,2',4,4',5,5'-HCB) did not produce a reduction in 3H-tyrosine uptake at any concentration tested. Thus, there were PCB concentrations at which a reduction in DA levels did not coincide with a decrease in 3H-tyrosine uptake, suggesting that inhibition of tyrosine uptake was not the primary mechanism by which PCBs reduce DA levels. Aroclor 1254-treated cells also exhibited elevated levels of DOPA, further supporting the conclusion that tyrosine levels were not limiting. Incubation of Aroclor 1254-pretreated cells with 3H-tyrosine resulted in a dose-dependent increase in cellular levels of 3H-DOPA and decrease in cellular levels of 3H-DA, suggesting a PCB-mediated inhibition of the conversion of 3H-DOPA to 3H-DA. When the media was supplemented with DOPA, Aroclor 1254-treated cells still exhibited reduced levels of DA, compared to control cells, even though the control and PCB-treated cells had similar cellular levels of DOPA. Thus, one mechanism by which PCBs may reduce cellular levels of DA is by inhibiting L-aromatic amino acid decarboxylase-mediated conversion of DOPA to DA. The PCB congeners, 2,2',4,4'-TCB, 2,2',5,5'-TCB, and 2,2',4,4',5,5'-HCB, also produced dose-dependent increases in DOPA levels. The congener 2,2',3,3',4,4'-HCB did not produce an increase in DOPA levels, although it did mediate reductions in cellular DA levels. However, when PC12 cells were supplemented with DOPA, all four PCB congeners produced a similar reduction in DA levels, suggesting that the conversion of DOPA to DA was inhibited by the PCBs.
PC12细胞被用于研究多氯联苯(PCBs)降低细胞内多巴胺(DA)水平的机制。在用Aroclor 1254、2,2',5,5'-四氯联苯(2,2',5,5'-TCB)或2,2',3,3',4,4'-六氯联苯(2,2',3,3',4,4'-HCB)处理3天的细胞中,仅在导致DNA水平降低的高PCB浓度下观察到PCB介导的3H-酪氨酸摄取减少。PCB同系物2,2',4,4',5,5'-六氯联苯(2,2',4,4',5,5'-HCB)在任何测试浓度下均未导致3H-酪氨酸摄取减少。因此,存在一些PCB浓度,此时DA水平的降低与3H-酪氨酸摄取的减少并不一致,这表明抑制酪氨酸摄取不是PCBs降低DA水平的主要机制。用Aroclor 1254处理的细胞中多巴(DOPA)水平也升高,进一步支持了酪氨酸水平不是限制因素的结论。用3H-酪氨酸孵育经Aroclor 1254预处理的细胞,导致细胞内3H-DOPA水平呈剂量依赖性增加,3H-DA水平降低,表明PCB介导了3H-DOPA向3H-DA转化的抑制作用。当培养基中添加DOPA时,与对照细胞相比,用Aroclor 1254处理的细胞中DA水平仍然降低,尽管对照细胞和经PCB处理的细胞中DOPA的细胞水平相似。因此,PCBs降低细胞内DA水平的一种机制可能是抑制L-芳香族氨基酸脱羧酶介导的DOPA向DA的转化。PCB同系物2,2',4,4'-TCB、2,2',5,5'-TCB和2,2',4,4',5,5'-HCB也使DOPA水平呈剂量依赖性增加。同系物2,2',3,3',4,4'-HCB虽然介导了细胞内DA水平的降低,但并未使DOPA水平升高。然而,当PC12细胞补充DOPA时,所有四种PCB同系物都使DA水平产生了类似程度的降低,这表明PCBs抑制了DOPA向DA的转化。